Low expression of HAGH (GLO2) as well as of LDHD was also prominently connected with poorer 5-year overall survival across different cancers (TCGA PANCAN dataset; N = 11,506 patients; Fig. 4D). The gene discussed is HAGH; the disease is cancer.